ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Ophthalmology

Top Ophthalmology Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
OMAR DUKAR M.D.

Ophthalmology

5,672

$493K

798
717 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

64%
prescriptions for brand name drugs

Avg: 61%

$87
Average prescription price

Avg: $76

CHRISTOPHER KNIGHT M.D.

Ophthalmology

4,585

$341K

905
825 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

67%
prescriptions for brand name drugs

Avg: 61%

$74
Average prescription price

Avg: $76

DANIEL TAGLIA M.D.

Ophthalmology

3,967

$247K

714
659 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

58%
prescriptions for brand name drugs

Avg: 61%

$62
Average prescription price

Avg: $76

ROBERT TROYER M.D.

Ophthalmology

3,804

$291K

552
508 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

61%
prescriptions for brand name drugs

Avg: 61%

$77
Average prescription price

Avg: $76

JOHN LATONA M.D.

Ophthalmology

3,675

$332K

751
661 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

63%
prescriptions for brand name drugs

Avg: 61%

$90
Average prescription price

Avg: $76

EDWARD BROCKMAN M.D.

Ophthalmology

3,193

$185K

892
769 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

29%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

59%
prescriptions for brand name drugs

Avg: 61%

$58
Average prescription price

Avg: $76

ROBERT WILLIAMSON M.D.

Ophthalmology

3,187

$171K

691
624 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

49%
prescriptions for brand name drugs

Avg: 61%

$54
Average prescription price

Avg: $76

JOHN PARENT M.D.

Ophthalmology

3,145

$181K

660
590 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

57%
prescriptions for brand name drugs

Avg: 61%

$58
Average prescription price

Avg: $76

HEMANG PATEL M.D.

Ophthalmology

3,067

$266K

530
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 61%

$87
Average prescription price

Avg: $76

SCOTT MILLER M.D.

Ophthalmology

3,025

$242K

578
549 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

67%
prescriptions for brand name drugs

Avg: 61%

$80
Average prescription price

Avg: $76

FRANCIS PRICE M.D.

Ophthalmology

3,017

$208K

636
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

73%
prescriptions for brand name drugs

Avg: 61%

$69
Average prescription price

Avg: $76

DOUGLAS WILLIAMS M.D.

Ophthalmology

2,991

$178K

632
592 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

63%
prescriptions for brand name drugs

Avg: 61%

$60
Average prescription price

Avg: $76

JOHN ABRAMS M.D.

Ophthalmology

2,980

$205K

727
655 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

58%
prescriptions for brand name drugs

Avg: 61%

$69
Average prescription price

Avg: $76

KAREN BRIGGS D.O.

Ophthalmology

2,975

$256K

425
392 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

69%
prescriptions for brand name drugs

Avg: 61%

$86
Average prescription price

Avg: $76

BRUCE GROSSNICKLE M.D.

Ophthalmology

2,956

$204K

849
781 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

74%
prescriptions for brand name drugs

Avg: 61%

$69
Average prescription price

Avg: $76

BARBARA SCHROEDER M.D.

Ophthalmology

2,843

$246K

589
558 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

63%
prescriptions for brand name drugs

Avg: 61%

$87
Average prescription price

Avg: $76

DAVID GROSS D.O.

Ophthalmology

2,767

$311K

803
724 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

83%
prescriptions for brand name drugs

Avg: 61%

$112
Average prescription price

Avg: $76

PAUL CACCHILLO M.D.

Ophthalmology

2,644

$212K

646
592 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

64%
prescriptions for brand name drugs

Avg: 61%

$80
Average prescription price

Avg: $76

THOMAS BRUMMER M.D.

Ophthalmology

2,601

$232K

610
554 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

76%
prescriptions for brand name drugs

Avg: 61%

$89
Average prescription price

Avg: $76

NICHOLAS RADER M.D.

Ophthalmology

2,516

$154K

499
457 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

49%
prescriptions for brand name drugs

Avg: 61%

$61
Average prescription price

Avg: $76

WILLIAM WHITSON MD

Ophthalmology

2,507

$183K

532
487 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

66%
prescriptions for brand name drugs

Avg: 61%

$73
Average prescription price

Avg: $76

MARK RENSHAW M.D.

Ophthalmology

2,385

$226K

538
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

76%
prescriptions for brand name drugs

Avg: 61%

$95
Average prescription price

Avg: $76

TERRY TALLEY MD

Ophthalmology

2,340

$193K

661
606 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

79%
prescriptions for brand name drugs

Avg: 61%

$82
Average prescription price

Avg: $76

MAX HENRY MD

Ophthalmology

2,299

$249K

452
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

79%
prescriptions for brand name drugs

Avg: 61%

$108
Average prescription price

Avg: $76

CHARLES MCCORMICK M.D.

Ophthalmology

2,287

$137K

525
486 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

49%
prescriptions for brand name drugs

Avg: 61%

$60
Average prescription price

Avg: $76

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank